New onset of myasthenia gravis after treatment of systemic sclerosis by autologous hematopoietic stem cell transplantation: Sustained autoimmunity or inadequate reset of tolerance?

Human Immunology

Volumn 71, Issue 4, 2010, Pages 363-365

  Deligny, Christophe ^a   Clave, Emmanuel ^b   Sibon, David ^b   Daikeler, Thomas ^b   Keshmandt, Homah ^b   Carmagnat, Maryvonnic ^b   Douay, Corinne ^b   Arfi, Serge ^a   Clair, Bernard ^c   Toubert, Antoine ^b   Farge, Dominique ^b  

^a Department of Internal Medicine and Rheumatology   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

Immune reconstitution; Myasthenia; Secondary autoimmune disease; Stem cell transplantation; Systemic sclerosis

Indexed keywords

AUTOANTIBODY; CD45RO ANTIGEN; CYCLOPHOSPHAMIDE; EDROPHONIUM; IMMUNOGLOBULIN; MUSCLE SPECIFIC TYROSINE KINASE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PYRIDOSTIGMINE; THYMOCYTE ANTIBODY; TOPOISOMERASE 1 ANTIBODY; UNCLASSIFIED DRUG; VALACICLOVIR;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CASE REPORT; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CELL EXPANSION; CELLULAR IMMUNITY; DIPLOPIA; DRUG DOSE REDUCTION; DRUG TOLERABILITY; FATIGUE; FEMALE; HERPES VIRUS INFECTION; HUMAN; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MEMORY CELL; MYASTHENIA GRAVIS; NERVE STIMULATION; PRIORITY JOURNAL; PTOSIS; SYSTEMIC SCLEROSIS; VIRUS REACTIVATION;

AUTOIMMUNITY; CELL PROLIFERATION; CELLS, CULTURED; DNA; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE TOLERANCE; MIDDLE AGED; MYASTHENIA GRAVIS; PATHOLOGY, MOLECULAR; POSTOPERATIVE COMPLICATIONS; RECEPTORS, ANTIGEN, T-CELL; REMISSION INDUCTION; SCLERODERMA, SYSTEMIC; T-LYMPHOCYTES; TRANSPLANTATION, AUTOLOGOUS;

EID: 77950522293     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.01.013     Document Type: Article

References (14)

1. Loh Y., Oyama Y., Statkute L., Quigley K., Yaung K., Gonda E., et al. Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: Role of conditioning regimen used. Blood 2007, 109:2643-2648.
2. Bohgaki T., Atsumi T., Koike T. Autoimmune disease after autologous hematopoietic stem cell transplantation. Autoimmun Rev 2008, 7:198-203.
3. Bohgaki T., Atsumi T., Koike T. Multiple autoimmune diseases after autologous stem-cell transplantation. N Engl J Med 2007, 357:2734-2736.
4. Farge D., Marolleau J.P., Zohar S., Marjanovic Z., Cabane J., Mounier N., et al. Intensification et Autogreffe dans les Maladies Auto Immunes Resistantes (ISAMAIR) Study Group. Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: Early results from a French multicentre phase I-II study. Br J Haematol 2002, 119:726-739.
5. Clave E., Rocha V., Talvensaari K., Busson M., Douay C., Appert M.L., et al. Prognostic value of pretransplantation host thymic function in HLA-identical sibling hematopoietic stem cell transplantation. Blood 2005, 105:2608-2613.
6. + immune regulatory network. Blood 2006, 107:1696-1702.
7. Talvensaari K., Clave E., Douay C., Rabian C., Garderet L., Busson M., et al. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 2002, 99:1458-1464.
8. Snowden J.A., Biggs J.C., Brooks P.M. Autologous blood stem cell transplantation for autoimmune diseases. Lancet 1996, 348:1112-1113.
9. Sherer Y., Shoenfeld Y. Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant 1998, 22:873-881.
10. Zivković S.A., Medsger T.A. Myasthenia gravis and scleroderma: Two cases and a review of the literature. Clin Neurol Neurosurg 2007, 109:388-391.
11. Dubinsky AN, Burt RK, Martin R, Muraro PA. T-cell clones persisting in the circulation after autologous hematopoietic SCT are undetectable in the peripheral CD34+ selected graft. Bone Marrow Transplant (in press).
12. Muraro A.P., Douek D.C., Packer A., Chung K., Guenaga F.J., Cassiani-Ingoni R., et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005, 201:805-816.
13. Farge D., Henegar C., Carmagnat M., Daneshpouy M., Marjanovic Z., Rabian C., et al. Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis. Arthritis Rheum 2005, 52:1555-1563.
14. Gratwohl A., Passweg J., Bocelli-Tyndall C., Fassas A., Van Laar J.M., Farge D., et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 2005, 35:869-879.